THERMO FISHER SCIENTIFIC INC (TN8.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:TN8 - US8835561023 - Common Stock
508.6 EUR
-2.4 (-0.47%)
Taking everything into account, TN8 scores 4 out of 10 in our fundamental rating. TN8 was compared to 19 industry peers in the Life Sciences Tools & Services industry. TN8 has only an average score on both its financial health and profitability. TN8 is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
TN8 had positive earnings in the past year.
TN8 had a positive operating cash flow in the past year.
TN8 had positive earnings in each of the past 5 years.
Each year in the past 5 years TN8 had a positive operating cash flow.
1.2 Ratios
The Return On Assets of TN8 (6.38%) is better than 73.68% of its industry peers.
The Return On Equity of TN8 (12.88%) is better than 73.68% of its industry peers.
The Return On Invested Capital of TN8 (6.43%) is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for TN8 is below the industry average of 9.25%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.38% | ||
| ROE | 12.88% | ||
| ROIC | 6.43% |
ROA(3y)6.58%
ROA(5y)7.42%
ROE(3y)13.8%
ROE(5y)15.76%
ROIC(3y)6.66%
ROIC(5y)7.62%
1.3 Margins
TN8's Profit Margin of 15.02% is fine compared to the rest of the industry. TN8 outperforms 73.68% of its industry peers.
TN8's Profit Margin has been stable in the last couple of years.
With a decent Operating Margin value of 18.40%, TN8 is doing good in the industry, outperforming 68.42% of the companies in the same industry.
In the last couple of years the Operating Margin of TN8 has grown nicely.
TN8's Gross Margin of 41.43% is in line compared to the rest of the industry. TN8 outperforms 52.63% of its industry peers.
TN8's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.4% | ||
| PM (TTM) | 15.02% | ||
| GM | 41.43% |
OM growth 3Y-12.04%
OM growth 5Y1.61%
PM growth 3Y-9.15%
PM growth 5Y0.42%
GM growth 3Y-6.24%
GM growth 5Y-1.42%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so TN8 is destroying value.
TN8 has less shares outstanding than it did 1 year ago.
The number of shares outstanding for TN8 has been reduced compared to 5 years ago.
The debt/assets ratio for TN8 has been reduced compared to a year ago.
2.2 Solvency
TN8 has a debt to FCF ratio of 5.84. This is a neutral value as TN8 would need 5.84 years to pay back of all of its debts.
TN8 has a Debt to FCF ratio (5.84) which is in line with its industry peers.
A Debt/Equity ratio of 0.62 indicates that TN8 is somewhat dependend on debt financing.
TN8 has a Debt to Equity ratio of 0.62. This is comparable to the rest of the industry: TN8 outperforms 42.11% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.62 | ||
| Debt/FCF | 5.84 | ||
| Altman-Z | N/A |
ROIC/WACC0.66
WACC9.78%
2.3 Liquidity
A Current Ratio of 1.50 indicates that TN8 should not have too much problems paying its short term obligations.
TN8 has a better Current ratio (1.50) than 63.16% of its industry peers.
A Quick Ratio of 1.11 indicates that TN8 should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.11, TN8 is in line with its industry, outperforming 57.89% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.5 | ||
| Quick Ratio | 1.11 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 4.53% over the past year.
TN8 shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 12.12% yearly.
Looking at the last year, TN8 shows a small growth in Revenue. The Revenue has grown by 3.22% in the last year.
Measured over the past years, TN8 shows a quite strong growth in Revenue. The Revenue has been growing by 10.92% on average per year.
EPS 1Y (TTM)4.53%
EPS 3Y-4.52%
EPS 5Y12.12%
EPS Q2Q%9.66%
Revenue 1Y (TTM)3.22%
Revenue growth 3Y3.03%
Revenue growth 5Y10.92%
Sales Q2Q%4.94%
3.2 Future
The Earnings Per Share is expected to grow by 9.66% on average over the next years. This is quite good.
The Revenue is expected to grow by 4.65% on average over the next years.
EPS Next Y5.02%
EPS Next 2Y6.77%
EPS Next 3Y7.78%
EPS Next 5Y9.66%
Revenue Next Year3.49%
Revenue Next 2Y4.24%
Revenue Next 3Y4.65%
Revenue Next 5Y4.65%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 26.26, which means the current valuation is very expensive for TN8.
TN8's Price/Earnings ratio is in line with the industry average.
TN8's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.31.
The Price/Forward Earnings ratio is 23.60, which indicates a rather expensive current valuation of TN8.
TN8's Price/Forward Earnings ratio is in line with the industry average.
When comparing the Price/Forward Earnings ratio of TN8 to the average of the S&P500 Index (36.56), we can say TN8 is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.26 | ||
| Fwd PE | 23.6 |
4.2 Price Multiples
TN8's Enterprise Value to EBITDA ratio is in line with the industry average.
TN8's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 36.17 | ||
| EV/EBITDA | 23.2 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates TN8 does not grow enough to justify the current Price/Earnings ratio.
TN8 has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)5.23
PEG (5Y)2.17
EPS Next 2Y6.77%
EPS Next 3Y7.78%
5. Dividend
5.1 Amount
With a yearly dividend of 0.29%, TN8 is not a good candidate for dividend investing.
TN8's Dividend Yield is slightly below the industry average, which is at 0.70.
Compared to an average S&P500 Dividend Yield of 2.32, TN8's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.29% |
5.2 History
On average, the dividend of TN8 grows each year by 15.42%, which is quite nice.
Dividend Growth(5Y)15.42%
Div Incr Years4
Div Non Decr Years4
5.3 Sustainability
TN8 pays out 9.48% of its income as dividend. This is a sustainable payout ratio.
TN8's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP9.48%
EPS Next 2Y6.77%
EPS Next 3Y7.78%
FRA:TN8 (11/28/2025, 7:00:00 PM)
508.6
-2.4 (-0.47%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners91.65%
Inst Owner ChangeN/A
Ins Owners0.09%
Ins Owner ChangeN/A
Market Cap191.09B
Revenue(TTM)43.74B
Net Income(TTM)6.57B
Analysts80.63
Price Target540.11 (6.2%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.29% |
Yearly Dividend1.31
Dividend Growth(5Y)15.42%
DP9.48%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.99%
Min EPS beat(2)1.61%
Max EPS beat(2)4.37%
EPS beat(4)3
Avg EPS beat(4)1.9%
Min EPS beat(4)-0.07%
Max EPS beat(4)4.37%
EPS beat(8)5
Avg EPS beat(8)2.24%
EPS beat(12)7
Avg EPS beat(12)1.19%
EPS beat(16)11
Avg EPS beat(16)4.2%
Revenue beat(2)2
Avg Revenue beat(2)0.79%
Min Revenue beat(2)0.62%
Max Revenue beat(2)0.95%
Revenue beat(4)4
Avg Revenue beat(4)0.47%
Min Revenue beat(4)0.04%
Max Revenue beat(4)0.95%
Revenue beat(8)6
Avg Revenue beat(8)0.12%
Revenue beat(12)7
Avg Revenue beat(12)0.36%
Revenue beat(16)11
Avg Revenue beat(16)2.75%
PT rev (1m)11.73%
PT rev (3m)12.11%
EPS NQ rev (1m)-0.01%
EPS NQ rev (3m)-1.16%
EPS NY rev (1m)1.01%
EPS NY rev (3m)1%
Revenue NQ rev (1m)-0.02%
Revenue NQ rev (3m)1.55%
Revenue NY rev (1m)0.65%
Revenue NY rev (3m)0.87%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.26 | ||
| Fwd PE | 23.6 | ||
| P/S | 5.05 | ||
| P/FCF | 36.17 | ||
| P/OCF | 28.89 | ||
| P/B | 4.33 | ||
| P/tB | N/A | ||
| EV/EBITDA | 23.2 |
EPS(TTM)19.37
EY3.81%
EPS(NY)21.55
Fwd EY4.24%
FCF(TTM)14.06
FCFY2.76%
OCF(TTM)17.6
OCFY3.46%
SpS100.65
BVpS117.42
TBVpS-33.38
PEG (NY)5.23
PEG (5Y)2.17
Graham Number226.22
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.38% | ||
| ROE | 12.88% | ||
| ROCE | 9.13% | ||
| ROIC | 6.43% | ||
| ROICexc | 6.7% | ||
| ROICexgc | 29.73% | ||
| OM | 18.4% | ||
| PM (TTM) | 15.02% | ||
| GM | 41.43% | ||
| FCFM | 13.97% |
ROA(3y)6.58%
ROA(5y)7.42%
ROE(3y)13.8%
ROE(5y)15.76%
ROIC(3y)6.66%
ROIC(5y)7.62%
ROICexc(3y)7.33%
ROICexc(5y)8.51%
ROICexgc(3y)36.42%
ROICexgc(5y)41.56%
ROCE(3y)9.48%
ROCE(5y)10.9%
ROICexgc growth 3Y-8.22%
ROICexgc growth 5Y1.35%
ROICexc growth 3Y-8.88%
ROICexc growth 5Y2.89%
OM growth 3Y-12.04%
OM growth 5Y1.61%
PM growth 3Y-9.15%
PM growth 5Y0.42%
GM growth 3Y-6.24%
GM growth 5Y-1.42%
F-Score8
Asset Turnover0.42
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.62 | ||
| Debt/FCF | 5.84 | ||
| Debt/EBITDA | 2.94 | ||
| Cap/Depr | 55.1% | ||
| Cap/Sales | 3.52% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 70.55% | ||
| Profit Quality | 93% | ||
| Current Ratio | 1.5 | ||
| Quick Ratio | 1.11 | ||
| Altman-Z | N/A |
F-Score8
WACC9.78%
ROIC/WACC0.66
Cap/Depr(3y)51.6%
Cap/Depr(5y)63.11%
Cap/Sales(3y)3.9%
Cap/Sales(5y)4.54%
Profit Quality(3y)109.9%
Profit Quality(5y)104.9%
High Growth Momentum
Growth
EPS 1Y (TTM)4.53%
EPS 3Y-4.52%
EPS 5Y12.12%
EPS Q2Q%9.66%
EPS Next Y5.02%
EPS Next 2Y6.77%
EPS Next 3Y7.78%
EPS Next 5Y9.66%
Revenue 1Y (TTM)3.22%
Revenue growth 3Y3.03%
Revenue growth 5Y10.92%
Sales Q2Q%4.94%
Revenue Next Year3.49%
Revenue Next 2Y4.24%
Revenue Next 3Y4.65%
Revenue Next 5Y4.65%
EBIT growth 1Y8.68%
EBIT growth 3Y-9.38%
EBIT growth 5Y12.7%
EBIT Next Year13.53%
EBIT Next 3Y9.14%
EBIT Next 5Y9.16%
FCF growth 1Y-6.66%
FCF growth 3Y2.29%
FCF growth 5Y12.42%
OCF growth 1Y-6.36%
OCF growth 3Y-2.36%
OCF growth 5Y11.75%
THERMO FISHER SCIENTIFIC INC / TN8.DE FAQ
What is the fundamental rating for TN8 stock?
ChartMill assigns a fundamental rating of 4 / 10 to TN8.DE.
What is the valuation status of THERMO FISHER SCIENTIFIC INC (TN8.DE) stock?
ChartMill assigns a valuation rating of 3 / 10 to THERMO FISHER SCIENTIFIC INC (TN8.DE). This can be considered as Overvalued.
What is the profitability of TN8 stock?
THERMO FISHER SCIENTIFIC INC (TN8.DE) has a profitability rating of 6 / 10.
What are the PE and PB ratios of THERMO FISHER SCIENTIFIC INC (TN8.DE) stock?
The Price/Earnings (PE) ratio for THERMO FISHER SCIENTIFIC INC (TN8.DE) is 26.26 and the Price/Book (PB) ratio is 4.33.
How sustainable is the dividend of THERMO FISHER SCIENTIFIC INC (TN8.DE) stock?
The dividend rating of THERMO FISHER SCIENTIFIC INC (TN8.DE) is 3 / 10 and the dividend payout ratio is 9.48%.